Sponsors and CROs are under mounting pressure to maximize return on investment (ROI), streamline processes, and deliver results without delays. While advancements in artificial intelligence dominate...
Read More
The FDA's final guidance on Conducting Clinical Trials With Decentralized Elements (September 2024) confirms that sponsors can shift trial activities such as telehealth visits, home-based...
Read More
Boston, MA, November 2024 – 20/20 Onsite continues to expand at the forefront of clinical research, delving deeper into the critical intersection of neurology and ophthalmology. With a growing number...
Read More
16 Oct. 2024 ( Business Weekly). A UK-US first ‘hi-tech EyeTech’ partnership has been unveiled by Cambridge’s Sano Genetics and American duo 20/20 Onsite in Everett, Massachusetts and Clinical...
Read More
The complexity and high costs associated with clinical trials make efficiency a top priority. With patient recruitment challenges, site management issues, and the need for high-quality data, many...
Read More
The DPHARM 2024 conference in Philadelphia convened the brightest minds in clinical research to explore innovations designed to modernize clinical trials and drive greater patient value. Jessica...
Read More
Ophthalmology assessments are pivotal in clinical trials, safeguarding participant health and ensuring accurate study outcomes. These evaluations identify potential side effects and verify treatment...
Read More
Katie Sigg, COT, OSA, OSC, has built her career around a simple belief: innovation in ophthalmology preserves vision and meaningfully improves patients' quality of life. She started as an ophthalmic...
Read More